OLSON ERIC R (Chief Scientific Officer) exercised options at SYROS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 4/4/2023ACC: 0001209191-23-022970
Officer· Chief Scientific Officer
Since Feb 2019
-623.00
Net shares
Net seller
$1.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
2K acquired · 2.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2K
Price / share
—
Trade value
—
% of position
33.5%
3/31/2023
5.97K→7.97K
Common Stock
Direct
Shares
−623.00
Price / share
$2.58
Trade value
$1.61K
% of position
7.8%
4/3/2023
7.97K→7.35K
Total
Net shares
+1.38K
Net value
-$1.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2023 | M · Option Exercise | +2K | — | — | 33.5% | 5.97K | 7.97K |
| Common Stock Direct | 4/3/2023 | F · Tax Withholding | −623.00 | $2.58 | $1.61K | 7.8% | 7.97K | 7.35K |
| Total | +1.38K | -$1.61K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
2K shares
Shares
−2K
Strike price
Held after
6K
Exercisable
—
3/31/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2K shares | 3/31/2023 | M · Option Exercise | −2K | — | 6K |